| For: | de Carvalho JF, Skare TL. Lidocaine in fibromyalgia: A systematic review. World J Psychiatry 2022; 12(4): 615-622 [PMID: 35582338 DOI: 10.5498/wjp.v12.i4.615] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v12/i4/615.htm |
| Number | Citing Articles |
| 1 |
F. Carabot, M.T. Valadés Periáñez, M.Á. Álvarez-Mon, A. Vidal Marcos. Fibromialgia. Medicine - Programa de Formación Médica Continuada Acreditado 2023; 13(92): 5427 doi: 10.1016/j.med.2023.12.001
|
| 2 |
Hance Clarke, Miki Peer, Sarah Miles, Mary-Ann Fitzcharles. Managing Pain in Fibromyalgia: Current and Future Options. Drugs 2025; 85(9): 1081 doi: 10.1007/s40265-025-02204-x
|
| 3 |
José Eduardo Martinez, Izabela Guimarães. “Fibromyalgia – are there any new approaches?”. Best Practice & Research Clinical Rheumatology 2024; 38(1): 101933 doi: 10.1016/j.berh.2024.101933
|
| 4 |
Yian Chen, Eric Wang, Brian D Sites, Steven P Cohen. Integrating mechanistic-based and classification-based concepts into perioperative pain management: an educational guide for acute pain physicians. Regional Anesthesia & Pain Medicine 2024; 49(8): 581 doi: 10.1136/rapm-2022-104203
|
| 5 |
Marta Magdalena Jaskólska, Iga Kościńska-Shukla, Kinga Grochowalska, Michał Olech, Zofia Mikołajczak, Magdalena Chylińska, Natalia Aleksandra Dułak, Magdalena Rytlewska, Paulina Pikus, Michał Chmielewski. From Autoimmune Sialadenitis to Central Pain: Hypothesizing Shared Pathogenesis for Fibromyalgia and Primary Sjogren’s Disease and Identifying Essential Screening Strategies. International Journal of Molecular Sciences 2025; 26(24): 11821 doi: 10.3390/ijms262411821
|
